Section one: Contracting authority
one.1) Name and addresses
NHS Blood and Transplant
500 North Bristol Park
Bristol
BS34 7QH
Contact
Catherine Sizer
Telephone
+44 7385435279
Country
United Kingdom
Region code
UKK11 - Bristol, City of
National registration number
NHS Blood and Transplant
Internet address(es)
Main address
Buyer's address
one.1) Name and addresses
Welsh Blood Service
Ely Valley Rd, Talbot Green, Ynysmaerdy,
Pontyclun
CF72 9WB
wbs.bloodhealthteam@wales.nhs.uk
Country
United Kingdom
Region code
UK - United Kingdom
Internet address(es)
Main address
https://www.welsh-blood.org.uk/
Buyer's address
https://www.welsh-blood.org.uk/
one.1) Name and addresses
Scottish National Blood Transfusion Service
The Jack Copland Centre 52 Research Avenue North Heriot-Watt Research Park
Edinburgh
EH14 4BE
Country
United Kingdom
Region code
UK - United Kingdom
Internet address(es)
Main address
Buyer's address
one.1) Name and addresses
Any NHS Authority or Trust
N/A
N/A
N/A
Country
United Kingdom
Region code
UK - United Kingdom
Internet address(es)
Main address
Buyer's address
one.2) Information about joint procurement
The contract involves joint procurement
In the case of joint procurement involving different countries, state applicable national procurement law
UK
one.3) Communication
Additional information can be obtained from the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Supply and maintenance of cell washing and processing systems
two.1.2) Main CPV code
- 33194210 - Blood-transfusion devices
two.1.3) Type of contract
Supplies
two.1.4) Short description
Supply and maintenance of cell washing and processing systems
two.1.5) Estimated total value
Value excluding VAT: £800,000
two.1.6) Information about lots
This contract is divided into lots: Yes
two.2) Description
two.2.1) Title
5. Lot 3 - The provision and maintenance of system(s) and associated consumables
Lot No
3
two.2.2) Additional CPV code(s)
- 33194210 - Blood-transfusion devices
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
Description
This Prior Information Notice (PIN) is separate to any tender opportunity and its purpose is to consult the market to improve NHSBT’s and the wider NHS’s knowledge of organisations within the marketplace that can offer the required service and to gauge market interest ahead of any further tender opportunity.
NHSBT require medical devices as follows
• Lot 1: The provision and maintenance of a cord blood cell separation system and associated consumables
• Lot 2: The provision and maintenance of system(s) and associated consumables designed to wash, re-suspend haematopoietic cell suspensions
• Lot 3: The provision and maintenance of system(s) and associated consumables designed to volume reduce bone marrow (<600ml).
Supplier materials will require appropriate conformite European (CE) marking up until 30 June 2024 however from 1 July 2024, devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended https://www.gov.uk/guidance/register-medical-devices-to-place-on-the-market.
Indicators
• Bids may cover parts or the whole contract.
• Award on basis of price and quality.
This UK Framework Agreement is for a period of 2 years with two 1-year options to extend. It is the intention of NHSBT to award a national Framework Agreement for these requirements by June 2023. The following contracting authorities will be able to purchase against the Framework Agreement: any NHS Authority or Trust, Welsh Blood Service and Scottish National Blood Transfusion Service.
two.2) Description
two.2.1) Title
4. Lot 2 - The provision and maintenance of system(s) and associated consumables
Lot No
2
two.2.2) Additional CPV code(s)
- 33194210 - Blood-transfusion devices
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
Description
This Prior Information Notice (PIN) is separate to any tender opportunity and its purpose is to consult the market to improve NHSBT’s and the wider NHS’s knowledge of organisations within the marketplace that can offer the required service and to gauge market interest ahead of any further tender opportunity.
NHSBT require medical devices as follows
• Lot 1: The provision and maintenance of a cord blood cell separation system and associated consumables
• Lot 2: The provision and maintenance of system(s) and associated consumables designed to wash, re-suspend haematopoietic cell suspensions
• Lot 3: The provision and maintenance of system(s) and associated consumables designed to volume reduce bone marrow (<600ml).
Supplier materials will require appropriate conformite European (CE) marking up until 30 June 2024 however from 1 July 2024, devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended https://www.gov.uk/guidance/register-medical-devices-to-place-on-the-market.
Indicators
• Bids may cover parts or the whole contract.
• Award on basis of price and quality.
This UK Framework Agreement is for a period of 2 years with two 1-year options to extend. It is the intention of NHSBT to award a national Framework Agreement for these requirements by June 2023. The following contracting authorities will be able to purchase against the Framework Agreement: any NHS Authority or Trust, Welsh Blood Service and Scottish National Blood Transfusion Service.
two.2) Description
two.2.1) Title
3. Lot 1 - The provision and maintenance of a cord blood cell separation system
Lot No
1
two.2.2) Additional CPV code(s)
- 33194210 - Blood-transfusion devices
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
Description
This Prior Information Notice (PIN) is separate to any tender opportunity and its purpose is to consult the market to improve NHSBT’s and the wider NHS’s knowledge of organisations within the marketplace that can offer the required service and to gauge market interest ahead of any further tender opportunity.
NHSBT require medical devices as follows
• Lot 1: The provision and maintenance of a cord blood cell separation system and associated consumables
• Lot 2: The provision and maintenance of system(s) and associated consumables designed to wash, re-suspend haematopoietic cell suspensions
• Lot 3: The provision and maintenance of system(s) and associated consumables designed to volume reduce bone marrow (<600ml).
Supplier materials will require appropriate conformite European (CE) marking up until 30 June 2024 however from 1 July 2024, devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended https://www.gov.uk/guidance/register-medical-devices-to-place-on-the-market.
Indicators
• Bids may cover parts or the whole contract.
• Award on basis of price and quality.
This UK Framework Agreement is for a period of 2 years with two 1-year options to extend. It is the intention of NHSBT to award a national Framework Agreement for these requirements by June 2023. The following contracting authorities will be able to purchase against the Framework Agreement: any NHS Authority or Trust, Welsh Blood Service and Scottish National Blood Transfusion Service.
two.3) Estimated date of publication of contract notice
1 March 2023
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes